Gerb 74ae417cc05ef25f84b0015d81454434f599579d3ac11b3bfaaa42f8e29a5826

BULLETIN
of the Ivanovo Medical AcademyISSN 1606-8157

Новости

Статистика


Logotip rgp 938b4d8cf58bb50340e3e564842b9c611ee8018249b093a9e8cd19b9d23ccaba

Issue: 2013, Vol. 18, No. 3

Batrak G. A., Myasoedova S. E., Kelesh O. I.

Nonlipid effects of micronizing phenofibrate in patients with 2 type diabetes and atherogenic dyslipidemia

Keywords
diabetes mellitus, dyslipidemia, endothelium function, C-reactive protein, phenofibrate
Abstarct
63 patients with 2 type diabetes and dyslipidemia were observed in order to study nonlipid effects of micronizing phenofibrate in the dose of 145 mg. The basic values dynamics was analyzed before and after 6 months of the administered treatment. The micronizing phenofibrate in complex therapy in patients with 2 type diabetes decreased C-reactive protein level for certain and improved endothelium function. The obtained indices of humeral artery diameter growth correlated with C-reactive protein level and to small extent depended on lipid and carbohydrate metabolism monitoring. It allowed to suppose that phenophibrate had nonlipid (pleiotropic) effects.

Скачать